From: Focal cryosurgical ablation of the prostate: a single institute’s perspective
Variables | |
---|---|
Age, years, median (range) | 65 (55-74) |
Race | n (%) |
White | 23 (88) |
Hispanic | 1 (4) |
Black | 2 (8) |
Pretreatment clinical stage | n (%) |
T1c | 26 (100) |
Gleason score in entry biopsy | n (%) |
3 + 3 | 25 (96) |
3 + 4 | 1 (4) |
PSA at pre-operative evaluation | n (%) |
</= 10 | 24 (92) |
10-20 | 2 (8) |
Entry staging biopsy (all patients) | |
Median performed, n (range) | 40 (30-60) |
Median cores positive for cancer, n (range) | 4 (1-6) |
Unilateral Cancer, n (%) | 24 (92) |
Bilateral Cancer, n (%) | 2 (8) |
Preoperative urinary continence, n (%) | 26(100) |
Preoperative SHIM score median, n (range) | 20 (16-25) |
Mean follow-up, months | 19.1 |